CN112915185A - Pharmaceutical composition and preparation method and application thereof - Google Patents
Pharmaceutical composition and preparation method and application thereof Download PDFInfo
- Publication number
- CN112915185A CN112915185A CN202110157358.5A CN202110157358A CN112915185A CN 112915185 A CN112915185 A CN 112915185A CN 202110157358 A CN202110157358 A CN 202110157358A CN 112915185 A CN112915185 A CN 112915185A
- Authority
- CN
- China
- Prior art keywords
- pharmaceutical composition
- lemon
- mature vinegar
- ginger
- garlic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8962—Allium, e.g. garden onion, leek, garlic or chives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Urology & Nephrology (AREA)
- Medicines Containing Plant Substances (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Cardiology (AREA)
Abstract
The invention discloses a pharmaceutical composition, a preparation method and application thereof, and relates to the technical field of medicines. The pharmaceutical composition comprises the following components in parts by weight: lemon, honey, ginger, garlic and mature vinegar; the lemon, the honey, the ginger and the garlic are in mass ratio: lemon: and (3) honey: ginger: garlic 130-170: 3-7: 130-170; the mass-volume ratio of the lemon to the mature vinegar is as follows: lemon: and (3) mature vinegar 13-17: 50 g/mL. After the pharmaceutical composition is taken for a plurality of days, the symptoms of chest pain and chest distress can be obviously improved, the chest pressure is eliminated, the blood vessels are dredged, the curative effect is quick, and the risk is low.
Description
Technical Field
The invention relates to the technical field of medicines, in particular to a pharmaceutical composition and a preparation method and application thereof.
Background
Chest pain is a very common disease, and chest pain is caused by work fatigue, disordered work and rest, cardiovascular diseases and the like. At present, the salvia miltiorrhiza dripping pills are generally used for treating symptoms such as chest pain, chest distress and the like caused by blood vessel blockage in clinic chest pain centers of hospitals, but the taking period is long, the curative effect is not obvious, the slight curative effect is achieved after the salvia miltiorrhiza dripping pills are generally taken for seven days, and the symptoms such as the chest distress, the chest pain and the like can relapse in a short period. In addition, the chest pain caused by cardiovascular diseases is usually treated by adopting a surgical operation method, and a stent is implanted into a human body to open blood vessels; however, the operation has certain risks, the audience is small and needs to take medicine for a long time, and the existence of the bracket can cause certain obstacles to the future life, physiology and psychology of the patient.
Disclosure of Invention
The invention aims to overcome the defects of the prior art and provides a pharmaceutical composition with quick response and good curative effect, a preparation method and application thereof.
In order to achieve the purpose, the technical scheme adopted by the invention is as follows: a pharmaceutical composition comprising the following ingredients: lemon, honey, ginger, garlic and mature vinegar; the lemon, the honey, the ginger and the garlic are in mass ratio: lemon: and (3) honey: ginger: garlic 130-170: 3-7: 130-170; the mass-volume ratio of the lemon to the mature vinegar is as follows: lemon: and (3) mature vinegar 13-17: 50 g/mL.
The lemon can regulate the permeability of blood vessels, prevent cardiovascular arteriosclerosis and reduce the viscosity of blood; the ginger can accelerate heartbeat and dilate blood vessels; bulbus Allii can prevent fat deposition in cardiovascular and cerebrovascular vessels, promote tissue fat metabolism, reduce cholesterol, lower blood concentration, promote vasodilatation, regulate blood pressure, promote blood circulation in blood vessel, inhibit thrombosis, and prevent arteriosclerosis; old vinegar can remove garbage in blood vessels; the applicant of the invention selects the proportion of the components, so that the prepared medicine composition has good effect of relieving chest pain and other symptoms caused by blood vessel blockage, and the taste of the medicine is improved by adding the honey into the components.
Preferably, the mass ratio of the lemon to the honey to the ginger to the garlic is 150:5:150: 150; the mass-volume ratio of the lemon to the mature vinegar is as follows: lemon: 15:50g/mL of mature vinegar.
Meanwhile, the invention also discloses a preparation method of the pharmaceutical composition, and equipment containing pig iron ingredients cannot be used in the preparation process of the pharmaceutical composition.
Preferably, the preparation method of the pharmaceutical composition comprises the following steps:
(1) crushing lemon, garlic and ginger into pulp, adding water, boiling, and preserving heat for 10-20 min to obtain a mixed solution A;
(2) filtering the mixed solution A to obtain a filtrate, adding mature vinegar and honey into the filtrate, extracting for 20-30 min, boiling with fast fire, and extracting with slow fire to obtain the pharmaceutical composition.
Preferably, the adding amount of the water in the step (1) is 40-60 vol.% of the adding amount of the mature vinegar in the step (2).
Further preferably, in the step (2), after boiling with fast fire, refining with slow fire for 25min to obtain the pharmaceutical composition.
In addition, the invention also discloses application of the pharmaceutical composition in dredging blood vessels and improving chest pain, chest distress and other diseases.
Compared with the prior art, the invention has the beneficial effects that: the raw materials of the pharmaceutical composition are common materials in life, the cost is low, patients can prepare the pharmaceutical composition at home, and the patients can keep normal daily work and activities during taking the pharmaceutical composition without side effects on human bodies. Compared with the conventional salvia miltiorrhiza dripping pill, the salvia miltiorrhiza dripping pill can take effect in a shorter time.
Detailed Description
To better illustrate the objects, aspects and advantages of the present invention, the present invention will be further described with reference to specific examples.
Example 1
In an embodiment of the pharmaceutical composition of the present invention, the preparation method of the pharmaceutical composition of this embodiment is as follows:
pulverizing 150g of lemon, 150g of garlic and 150g of ginger into pulp by using a beater, pouring into a container without pig iron, adding 250mL of distilled water, boiling, preserving heat for 15 minutes, filtering, adding 5g of honey and 500mL of mature vinegar into filtrate, boiling with fast fire, and refining with slow fire for 25 minutes to obtain the pharmaceutical composition.
Comparative example 1
A pharmaceutical composition, the preparation method of the pharmaceutical composition is as follows:
crushing 100g of lemon, 180g of garlic and 170g of ginger into pulp by using a beater, pouring the pulp into a container without pig iron, adding 250mL of distilled water to boil, preserving heat for 15 minutes, filtering, adding 5g of honey and 500mL of mature vinegar into filtrate, boiling with fast fire, and refining with slow fire for 25 minutes to obtain the pharmaceutical composition.
Comparative example 2
A pharmaceutical composition, the preparation method of the pharmaceutical composition is as follows:
pulverizing 150g of lemon, 150g of garlic and 150g of ginger into pulp by using a beater, pouring into a container without pig iron, adding 250mL of distilled water, boiling, preserving heat for 15 minutes, filtering, adding 5g of honey and 500mL of mature vinegar into filtrate, boiling with fast fire, and refining with slow fire for 40 minutes to obtain the pharmaceutical composition.
And (3) testing the drug effect:
6 adult patients with chest pain recently appeared were selected and divided into 3 groups of 2 patients, and the drug effects of example 1 and comparative examples 1 to 2 were evaluated.
The feedback results 3 days after administration and 1 month after completion of administration are shown in table 1, in which example 1 and comparative examples 1 to 2 were divided into 9 portions, and administered one portion each in the morning, in the middle of the day, and in the evening, for 3 days.
TABLE 1
As can be seen from table 1, the ratio of the lemon, the garlic, the ginger and the mature vinegar is selected, and the preparation time is controlled, so that the prepared pharmaceutical composition can eliminate chest pain of a patient within 3 days, and prevent the chest pain from recurring.
Finally, it should be noted that the above embodiments are only used for illustrating the technical solutions of the present invention and not for limiting the protection scope of the present invention, and although the present invention has been described in detail with reference to the preferred embodiments, it should be understood by those skilled in the art that modifications or equivalent substitutions can be made on the technical solutions of the present invention without departing from the spirit and scope of the technical solutions of the present invention.
Claims (7)
1. A pharmaceutical composition comprising the following components: lemon, honey, ginger, garlic and mature vinegar; the lemon, the honey, the ginger and the garlic are in mass ratio: lemon: and (3) honey: ginger: garlic 130-170: 3-7: 130-170; the mass-volume ratio of the lemon to the mature vinegar is as follows: lemon: and (3) mature vinegar 13-17: 50 g/mL.
2. The pharmaceutical composition according to claim 1, wherein the mass ratio of the lemon, the honey, the ginger and the garlic is 150:5:150: 150; the mass-volume ratio of the lemon to the mature vinegar is as follows: lemon: 15:50g/mL of mature vinegar.
3. A process for the preparation of a pharmaceutical composition according to any one of claims 1 to 2, wherein no equipment containing pig iron components is used in the preparation.
4. A process for preparing a pharmaceutical composition according to claim 3, comprising the steps of:
(1) crushing lemon, garlic and ginger into pulp, adding water, boiling, and preserving heat for 10-20 min to obtain a mixed solution A;
(2) filtering the mixed solution A to obtain a filtrate, adding mature vinegar and honey into the filtrate, extracting for 20-30 min, boiling with fast fire, and extracting with slow fire to obtain the pharmaceutical composition.
5. The method for preparing a pharmaceutical composition according to claim 4, wherein the water is added in an amount of 40 to 60 vol.% of the mature vinegar.
6. The method for preparing the pharmaceutical composition according to claim 5, wherein in the step (2), the pharmaceutical composition is obtained by boiling with fast fire and then refining with slow fire for 25 min.
7. The use of the pharmaceutical composition of any one of claims 1-2 for dredging blood vessels and improving chest pain and chest distress.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110157358.5A CN112915185A (en) | 2021-02-04 | 2021-02-04 | Pharmaceutical composition and preparation method and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110157358.5A CN112915185A (en) | 2021-02-04 | 2021-02-04 | Pharmaceutical composition and preparation method and application thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN112915185A true CN112915185A (en) | 2021-06-08 |
Family
ID=76170547
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110157358.5A Pending CN112915185A (en) | 2021-02-04 | 2021-02-04 | Pharmaceutical composition and preparation method and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112915185A (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105477585A (en) * | 2014-10-13 | 2016-04-13 | 孙茂忠 | Medicine for treating hemiplegia caused by stroke |
CN107568650A (en) * | 2017-08-31 | 2018-01-12 | 谷振宇 | A kind of health maintenance formula for dredging vascellum |
-
2021
- 2021-02-04 CN CN202110157358.5A patent/CN112915185A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105477585A (en) * | 2014-10-13 | 2016-04-13 | 孙茂忠 | Medicine for treating hemiplegia caused by stroke |
CN107568650A (en) * | 2017-08-31 | 2018-01-12 | 谷振宇 | A kind of health maintenance formula for dredging vascellum |
Non-Patent Citations (1)
Title |
---|
孟拓: ""通血管古方"真的管用吗", 《食品与生活》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102100273A (en) | High blood fat, high blood pressure and high blood sugar balancing tea and preparation method thereof | |
CN103520435A (en) | Agilawood health care essential oil | |
CN112915185A (en) | Pharmaceutical composition and preparation method and application thereof | |
CN100350921C (en) | Dermatosis eliminating medicine | |
CN100415293C (en) | Biological collagen oral liquor and preparing method | |
CN1660345A (en) | Prepared Chinese medicine for treating burn and scald | |
CN106912925A (en) | A kind of three high definition preparations and preparation method thereof | |
CN103599438B (en) | A kind of Traditional Chinese medicine tincture for the treatment of osteopathia and preparation method thereof | |
CN105998263A (en) | Externally-applied pharmaceutical composition for reducing hypertension, hyperglycemia and hyperlipemia and preparation method thereof | |
CN102579688B (en) | Blood pressure reducing chrysanthemum and dogbane leaf traditional Chinese medicine preparation | |
CN111166849A (en) | Medicated bath composition for removing fatigue and improving sleep | |
CN100384442C (en) | Chinese herbal medicine preparation and its preparing process and application | |
CN112076305A (en) | A Chinese medicinal oral and topical stock solution mixture for treating metabolic syndrome and resisting bacteria and inflammation | |
CN102755444A (en) | Traditional Chinese medicine composition for treating hyperlipidemia and preparation method thereof | |
CN108379510A (en) | A kind of Chinese medicine composition for treating angiocardiopathy | |
CN114767794B (en) | Traditional Chinese medicine for treating arterial plaque | |
CN103341015B (en) | Medicine for treating three-highs and preparation method thereof | |
CN102552640B (en) | Medicine for promoting fracture healing | |
CN100569252C (en) | The medicine and the preparation method of treatment essential hypertension | |
CN1264590A (en) | Medicine for treating leukoderma and preparing process thereof | |
CN113244324A (en) | Citicoline combined medicine and preparation method and application thereof | |
CN104096112A (en) | Traditional Chinese medicine composition for treating angina pectoris | |
CN105031353B (en) | A kind of logical Chinese medicine preparation of heart and brain | |
CN104645244A (en) | Traditional Chinese medicine composition for treating atherosclerosis | |
CN104509787A (en) | Healthful porridge for prevention of gestational diabetes mellitus and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210608 |
|
RJ01 | Rejection of invention patent application after publication |